Skip to main content

ELIMITE

Generic: permethrin

Verified·Apr 23, 2026
Manufacturer
Sebela Pharmaceuticals
NDC
59651-834
RxCUI
106387
Route
TOPICAL
ICD-10 indication
B86

Affordability Check

How much will you actually pay for ELIMITE?

In 30 seconds, see every legitimate way to afford ELIMITE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About ELIMITE

What is this medication? ELIMITE is a prescription topical cream containing 5 percent permethrin, which belongs to a class of drugs known as scabicides. It is primarily used for the treatment of infestations caused by Sarcoptes scabiei, more commonly known as scabies. The medication works by disrupting the nervous system of the mites, which leads to their paralysis and eventual death. It also targets the eggs of the mites to prevent new mites from hatching and continuing the infestation cycle. The cream is typically applied to the entire body from the neck down to the soles of the feet, including areas between the fingers and toes. It is usually left on the skin for eight to fourteen hours before being thoroughly washed off in a shower or bath. While a single application is often sufficient to eliminate the infestation, a healthcare provider may recommend a second treatment if live mites are still present after one week. It is also important for patients to wash all recently used clothing and bedding in hot water to prevent being reinfected by mites remaining in the environment.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for ELIMITE. Official source: DailyMed (NLM) · Label effective Jan 24, 2024

Indications and usage
INDICATIONS AND USAGE ELIMITE ® (permethrin) 5% Cream is indicated for the treatment of infestation with Sarcoptes scabiei (scabies).
Dosage and administration
DOSAGE AND ADMINISTRATION Adults and Children - Thoroughly massage ELIMITE ® (permethrin) 5% Cream into the skin from the head to the soles of the feet. Scabies rarely infests the scalp of adults, although the hairline, neck, temple, and forehead may be infested in infants and geriatric patients. Usually 30 grams is sufficient for an average adult. The cream should be removed by washing (shower or bath) after 8 to 14 hours. Infants should be treated on the scalp, temple, and forehead. ONE APPLICATION IS GENERALLY CURATIVE. Patients may experience persistent pruritus after treatment. This is rarely a sign of treatment failure and is not an indication for retreatment. Demonstrable living mites after 14 days indicate that retreatment is necessary.
Contraindications
CONTRAINDICATIONS ELIMITE ® (permethrin) 5% Cream is contraindicated in patients with known hypersensitivity to any of its components, to any synthetic pyrethroid or pyrethrin.
Warnings
WARNINGS If hypersensitivity to ELIMITE ® (permethrin) 5% Cream occurs, discontinue use.
Adverse reactions
ADVERSE REACTIONS In clinical trials, generally mild and transient burning and stinging followed application with ELIMITE ® (permethrin) 5% Cream in 10% of patients and was associated with the severity of infestation. Pruritus was reported in 7% of patients at various times post-application. Erythema, numbness, tingling, and rash were reported in 1 to 2% or less of patients (see PRECAUTIONS: General ). Other adverse events reported since marketing ELIMITE ® (permethrin) 5% Cream include: headache, fever, dizziness, abdominal pain, diarrhea and nausea and/or vomiting. Although extremely uncommon and not expected when used as directed (see DOSAGE AND ADMINISTRATION ), rare occurrences of seizure have been reported. None have been medically confirmed as associated with ELIMITE ® treatment.
Use in pregnancy
Pregnancy - Reproduction studies have been performed in mice, rats, and rabbits (200 to 400 mg/kg/day orally) and have revealed no evidence of impaired fertility or harm to the fetus due to permethrin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How ELIMITE appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

71%

3,929 of 5,509 plans

Most common tier

Tier 3

On 43% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)81
25%
Tier 2 (generic)104
32%
Tier 3 (preferred brand)143
43%
Tier 4 (non-preferred brand)1
0%

Step therapy: 0% of formularies

Quantity limits: 52% of formularies

Coverage breadth: 329 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.